IMBRIUM THERAPEUTICS Trademark

Trademark Overview

On Monday, August 27, 2018, a trademark application was filed for IMBRIUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the IMBRIUM THERAPEUTICS trademark a serial number of 88977444. The federal status of this trademark filing is REGISTERED as of Tuesday, June 9, 2020. This trademark is owned by Purdue Pharma L.P.. The IMBRIUM THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system disorders
imbrium therapeutics

General Information

Serial Number88977444
Word MarkIMBRIUM THERAPEUTICS
Filing DateMonday, August 27, 2018
Status700 - REGISTERED
Status DateTuesday, June 9, 2020
Registration Number6076740
Registration DateTuesday, June 9, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of central nervous system disorders
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 6, 2018
Primary Code005
First Use Anywhere DateTuesday, September 24, 2019
First Use In Commerce DateTuesday, September 24, 2019

Trademark Owner History

Party NamePurdue Pharma L.P.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901
Party NamePurdue Pharma L.P.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressStamford, CT 06901

Trademark Events

Event DateEvent Description
Tuesday, June 9, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, May 6, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 5, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 20, 2020ASSIGNED TO EXAMINER
Thursday, April 16, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, March 23, 2020USE AMENDMENT FILED
Thursday, April 16, 2020DIVISIONAL PROCESSING COMPLETE
Monday, March 23, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, April 15, 2020RESPONSE TO ITU OFFICE ACTION ENTERED
Wednesday, April 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 14, 2020ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
Tuesday, April 14, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 23, 2020TEAS STATEMENT OF USE RECEIVED
Monday, March 23, 2020TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 21, 2019ASSIGNED TO LIE
Wednesday, June 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 10, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 11, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 11, 2018NON-FINAL ACTION E-MAILED
Tuesday, December 11, 2018NON-FINAL ACTION WRITTEN
Monday, December 10, 2018ASSIGNED TO EXAMINER
Thursday, September 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 30, 2018NEW APPLICATION ENTERED

Related Keywords

therapeutics imbrium system disorders nervous central preparations treatment pharmaceutical